CorVel Corporation (CRVL)

Over the past six months, CorVel's stock price has experienced a significant decline. As of December 19, 2025, the share price was $68.78, representing a 38.98% decline from $112.72 on December 23, 2024. Key events impacting the stock include a three-for-one stock split in December 2024, Q4 and Fiscal Year 2025 earnings report (May 22, 2025) with revenues of $232 million for the quarter and $896 million for the fiscal year, Q3 2025 earnings report (November 4, 2025) with EPS of $0.54 and revenue of $240 million, insider selling, a downgrade in analyst sentiment from "Buy" to "Hold", and oversold conditions in early December 2025 and early January 2026.

Information directly detailing the demand seasonality for CorVel Corp.'s products and services is not explicitly available. Demand for its services would likely be influenced by factors such as economic activity and employment levels, regulatory changes, industry-specific trends, and catastrophic events. The company's fiscal year ends on March 31, and while financial reports show quarterly revenues, they do not explicitly discuss seasonal variations in demand for their services.

CorVel Corporation is a technology-driven provider of risk management solutions, specializing in workers' compensation, liability, and specialty risk management. Founded in 1987 in Fort Worth, Texas, CorVel develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. The company's integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support. The company's major products and services are delivered through two primary segments: Patient Management Services and Network Solutions Services. Key offerings include claims management, medical bill review and negotiation, preferred provider networks (PPO), virtual care and telehealth services, pharmacy benefit management (PBM), case management and utilization review, AI-driven analytics platforms, and Medicare solutions.

CorVel Corporation has expanded its footprint across the United States, serving insurance carriers, third-party administrators, self-insured employers, and government entities. The company is licensed to do business in all 50 states, the District of Columbia, and Puerto Rico. CorVel maintains a nationwide presence through a network of branches, with its principal executive offices and a centrally located hub in Fort Worth, Texas. Its Dallas-Fort Worth metropolitan area offices handle both workers' compensation and group health services.

CorVel's brand reputation appears generally positive in terms of operational performance and technological advancements, but there have been some historical concerns regarding its financial reporting and transparency. The company is recognized for its "high-tech, high-touch" approach and has been praised for revitalizing return-to-work programs and its forward-thinking approach. Strategic investments in AI, machine learning, and natural language processing are seen as key differentiators. However, a 2020 report raised concerns about CorVel's financial controls, and the company has been noted for keeping an unusually low profile, potentially contributing to a perception of a lack of transparency.

CorVel Corp. has a mixed ownership structure comprising institutional, insider, and retail investors. Approximately 42.93% to 54% of the company's stock is held by institutional investors. Insiders hold a significant portion, approximately 43.69% to 46.80% of the company's stock, with Corstar Holdings Inc. being the largest individual shareholder. Retail investors hold a smaller percentage, around 0.17% to 13.38%.